• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Home Health to Pharma

Anonymous

Guest
Generally speaking, to the non-competes/solicites signed when in home health sales prevent you from legally switching to pharma? It seems like it shouldn't be a conflict of interest. After all, marketing a drug to a doctor (referral source) isnt't going to hurt the bottom line of the home health agency you are trying to leave.